Last reviewed · How we verify
NCT05819437: ANGELLO
Knee Osteoarthritis and Balneotherapy
NA trial testing Balneotherapy program in Knee Osteoarthritis in 173 participants. Completed in 20 September 2022.
3 July 2021
Quick facts
| Lead sponsor | CEN Biotech |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 173 |
| Start date | 26 August 2020 |
| Primary completion | 3 July 2021 |
| Estimated completion | 20 September 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Balneotherapy program
Conditions studied
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Sponsor
CEN Biotech — full company profile →
Who can join
Adults 50 to 80, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to assess the efficacy of a 18-day balneotherapy program in the rheumatology indication in patients presented with knee osteoarthritis. The main questions of the study aims to answer are how balneotherapy improves functional incapacity and the disorders (pain, joint stiffness) induced by osteoarthritis of the knee, and thus improves patients' quality of life. Participants are randomly assigned in control or treatment (spa) groups. All receive standard of care for knee osteoarthritis throughout the study. Balneotherapy program consists of 18-days of spa treatment with Mineral Water of Saint Jean d'Angely. Functional incapacity, disorders and quality of life induced were measured at baseline and then 6 months later. Variation from baseline were compared in control and treatment groups to assess the efficacy of the balneotherapy program.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The effectiveness of a 3-week spa therapy on the 6-month mobility and functional ability of patients with knee osteoarthritis: the ANGELLO randomized controlled trial.
Forestier R, Debiais F, Michel N, Schueller R, et al · · 2025 · cited 1× · PMID 40358707 · DOI 10.1007/s00484-025-02927-2 -
Efficacy and safety of balneotherapy in rheumatology: a systematic review and meta-analysis.
Aribi I, Nourredine M, Giroudon C, Massy E, et al · · 2025 · cited 1× · PMID 40010834 · DOI 10.1136/bmjopen-2024-089597
Verify or expand the search:
- PubMed search for NCT05819437
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Osteoarthritis
Currently open trials in the same condition.
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
- NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting
Other CEN Biotech trials
Trials by the same sponsor.
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07295678 — URGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis · NA · not yet recruiting
- NCT06617975 — Knee Osteoarthritis and Spa Therapy · NA · recruiting
- NCT06278324 — Effectiveness of a Nasal Spray on Viral Respiratory Infections · NA · completed
- NCT06054737 — Chronic Venous Insufficiency and Balneotherapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05819437 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CEN Biotech
- Last refreshed: 19 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05819437.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing